クラウド、CI/CD、監視、デプロイ（7,167 件）
When picking a secrets store, designing rotation, or wiring scanning gates — multi-cloud (Vault, AWS, Azure, GCP), CI and Kubernetes — decision framework, provider deep-dives externalized.
日本語の概要は準備中です。原文の説明を表示しています。
Use when establishing what observability a project actually has — the four Golden Signals, required signal to detected implementation to evidence, and SLI/SLO provenance.
日本語の概要は準備中です。原文の説明を表示しています。
Use when working with Grafana — dashboards, Loki LogQL queries, alerting rules, monitoring panels — even when the user just says 'build me a dashboard' or 'query the logs' without naming Grafana.
日本語の概要は準備中です。原文の説明を表示しています。
Use when setting up Laravel Pulse — real-time dashboard, built-in cards, custom recorders, performance insights — even when the user just says 'I need app monitoring' without naming Pulse.
日本語の概要は準備中です。原文の説明を表示しています。
Use when configuring Laravel Reverb — the first-party WebSocket server with Pusher protocol compatibility, horizontal scaling, and Pulse monitoring.
日本語の概要は準備中です。原文の説明を表示しています。
Use when working with Docker — Dockerfile edits, docker-compose services, containers, or the dual-container (fast + Xdebug) setup — even when the user just says 'my container won't start'.
日本語の概要は準備中です。原文の説明を表示しています。
Use when filling knowledge-layer context files — auth-model, tenant-boundaries, data-sensitivity, deployment-order, observability — interactive template walkthrough.
日本語の概要は準備中です。原文の説明を表示しています。
Use when working with AWS resources — ECS Fargate, ECR, EFS, Secrets Manager, gomplate templates, multi-env deployments — even when the user says 'deploy to staging' without naming AWS.
日本語の概要は準備中です。原文の説明を表示しています。
Provides monitoring schedule for transgender males on testosterone therapy, detailing timing of clinical visits, laboratory tests, and assessment for virilization and adverse reactions. It is triggered when a clinician manages a transgender male patient on gender‑affirming hormone therapy and needs to schedule appropriate follow‑up.
日本語の概要は準備中です。原文の説明を表示しています。
This skill indicates the need for periodic prolactin monitoring in transgender females undergoing estrogen therapy. Clinical triggers include a transgender female patient receiving estrogen treatment.
日本語の概要は準備中です。原文の説明を表示しています。
Provides schedule for monitoring during sex hormone induction. Trigger: patient initiating gender-affirming hormone therapy (GAHT).
日本語の概要は準備中です。原文の説明を表示しています。
Provides monitoring schedule for transgender females on estrogen therapy, including clinical evaluation, hormone levels, prolactin, electrolytes, BMD, and cancer screening. Triggered when a transgender female is receiving estrogen therapy for gender affirmation.
日本語の概要は準備中です。原文の説明を表示しています。
This skill suggests using real-time continuous glucose monitoring (CGM) and algorithm-driven insulin pumps (ADIPs) rather than multiple daily injections (MDIs) with self-monitoring of blood glucose (SMBG) three or more times daily for adults and children with type 1 diabetes (T1D). Trigger phrases include "Should I use RT-CGM+ADIP or MDI+SMBG for this T1D patient?" or "Is intensive pump therapy indicated for this patient?"
日本語の概要は準備中です。原文の説明を表示しています。
Provides a monitoring schedule for patients receiving GnRH agonist therapy for pubertal suppression. Trigger phrases include 'patient undergoing GnRH agonist therapy' or 'initiating pubertal suppression'.
日本語の概要は準備中です。原文の説明を表示しています。
Recommends CGM over SMBG for type 1 diabetes patients on multiple daily injections to reduce hypoglycemia risk. Triggered by clinician questions such as "Should I use CGM or SMBG for this T1D patient on MDI?" or "Is CGM preferred for glucose monitoring in this patient?"
日本語の概要は準備中です。原文の説明を表示しています。
This skill checks for contraindications or sources of inaccuracy that may affect continuous glucose monitoring (CGM) reliability in hospitalized adults. It is triggered when clinicians ask, “Are there factors that could make CGM unreliable?” or when assessing for skin infection, hypoperfusion, hypovolemia, vasoactive/pressor therapy, or medications such as acetaminophen >4 g/day, dopamine, vitamin C, or hydroxyurea.
日本語の概要は準備中です。原文の説明を表示しています。
This skill suggests using real-time continuous glucose monitoring (CGM) rather than no CGM for outpatients with type 2 diabetes (T2D) who take insulin and/or sulfonylureas and are at high risk for hypoglycemia. It is triggered by clinician questions such as "Should I use CGM for this T2D patient on insulin or sulfonylureas with high hypoglycemia risk?" or "Is CGM indicated for this patient?"
日本語の概要は準備中です。原文の説明を表示しています。
The skill suggests using real-time continuous glucose monitoring (CGM) combined with algorithm-driven insulin pumps (ADIPs) rather than multiple daily injections (MDIs) with self-monitoring of blood glucose (SMBG) three or more times daily for adults and children with type 1 diabetes (T1D) to lower hypoglycemia incidence. Clinical triggers include discussions about insulin pump therapy, CGM use, or reducing hypoglycemia in T1D patients on intensive insulin regimens.
日本語の概要は準備中です。原文の説明を表示しています。
Suggests either continuous glucose monitor (CGM) or self-monitoring of blood glucose (SMBG) for pregnant individuals with type 2 diabetes. Triggers include decisions about glucose monitoring methods for pregnant patients with T2DM needing a monitoring strategy.
日本語の概要は準備中です。原文の説明を表示しています。
Confirms patient understands that continuous glucose monitoring complements but does not replace self-monitoring of blood glucose. Triggers include: 'Clarify CGM role alongside fingersticks', 'Ensure patient knows CGM does not eliminate need for SMBG'.
日本語の概要は準備中です。原文の説明を表示しています。
Suggests CSII with good adherence to monitoring and dosing for adults with type 2 diabetes mellitus who have poor glycemic control despite intensive insulin therapy, oral agents, other injectable therapy, and lifestyle modifications. Trigger phrases include 'T2DM on multiple injectables still uncontrolled' and 'Consider pump for insulin-requiring T2DM failing other therapies'.
日本語の概要は準備中です。原文の説明を表示しています。
This skill guides clinicians to reassess glucose monitoring frequency when discontinuing continuous subcutaneous insulin infusion (CSII) or transitioning to multiple daily injections (MDI). It is triggered by phrases such as 'Plan for glucose monitoring after pump stop' or 'Determine SMBG/CGM frequency post-pump' to ensure individualized glycemic goals are met.
日本語の概要は準備中です。原文の説明を表示しています。
Suggests initiating inpatient continuous glucose monitoring (CGM) for select hospitalized patients at high risk for hypoglycemia, combined with periodic point-of-care glucose checks for accuracy. Triggers include planning glucose monitoring for inpatients with prior severe hypoglycemia, renal or hepatic dysfunction, or age 65 years or older.
日本語の概要は準備中です。原文の説明を表示しています。
Recommends real-time continuous glucose monitoring (RT-CGM) for adult patients with type 1 diabetes mellitus (T1DM) whose hemoglobin A1C is above individualized target. Consider when clinician notes 'T1DM A1C above goal, consider RT-CGM' or 'Patient willing to wear CGM daily, A1C elevated'.
日本語の概要は準備中です。原文の説明を表示しています。